Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective.

Moreover, there may be significant disconnect between patient and physician perceptions surrounding this decision, as has been reported for other aspects of RA management, such as patient versus physician priorities for symptom improvement 18 and assessment of disease severity. 16 As such, there may be unique value in determining the patient perspective.

also in 13,097 other papers